International Stem Cell CORP (ISCO) stock

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30

$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

International Stem Cell total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

International Stem Cell has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in International Stem Cell's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-150 reverse split on Jul 29, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing